SEP 14, 2016 6:17 AM PDT

Scientists Uncover a Molecular Pac-Man that May Fight Cancer

WRITTEN BY: Xuan Pham
In researching how the breast clears out cells after the milk supply is finished, scientists at the University of Sheffield have inadvertently identified a protein that may help curb cancer growth. The protein of interest appears to gobble up nearby dead cells to prevent inflammation, kind of like a molecular Pac-Man.


 "It is thought that we shed the equivalent of our own body weight in dead cells every year," said Nasreen Ahktar, professor at the Sheffield’s Department of Oncology and Metabolism. But where do these cells go? How does the body get rid of them?
 
To answer this puzzle, Ahktar and his team focused on the breast, which is well known to undergo major changes before, during, and after lactation. In particular, when the job of producing milk is finished, the breast alveoli cells revert back to pre-pregnancy state. In studying this process, Ahktar and his team discovered a protein named Rac1.
 
Rac1 is apparently important for both stimulating the alveoli cells to secrete milk, but it is also vital in cell removal after the milk dries up. The Rac1 signal seems to tell cells to “eat” neighboring cells that are dead or dying. This clears up cellular debris and promotes renewal.
 
"By doing the job themselves, the breast epithelia limit both the numbers and time of immune phagocyte infiltration which protects the tissue from becoming damaged,” said Ahktar. "Without Rac1, the dead cells and milk flood the interconnecting breast ducts causing them to bloat and triggering chronic inflammation. The bloated ducts then fail to regenerate and produce milk in a future pregnancy."
 

While the results are significant in the field of developmental biology, Ahktar’s team is hopeful that this process can be applied to cancer biology. If in normal cells, Rac1 promotes cellular phagocytosis and reduce inflammation, how do cancer cells use (or abuse) Rac1? And more importantly, can scientists tame this protein and direct it against cancer? Answering these questions and more may provide a therapeutic target for curbing cancer’s growth.
 
But first, scientists have to contend with a contradiction. "Rac1 is over expressed in various cancers including breast cancer and Rac1 inhibitors are currently being considered as anticancer therapies,” said Ahktar. By contrast, Ahktar’s findings seem to suggest blocking Rac1 would be a bad idea.  
 
In particular, Ahktar said, "… in the breast, one of [Rac1’s] central roles is to prevent harmful inflammatory responses. Without Rac1 these responses are heightened and prolonged within tissues.”
 
The results underscore the need for further research into understanding the mechanism behind this molecular Pac-Man.
 
Additional source: The University of Sheffield
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 06, 2020
Immunology
APR 06, 2020
Clearing the Path for Dendritic Cells to Eliminate Tumors
  Dendritic cells are the sentinels of the immune system and use their “tree-like” projections to prese ...
MAY 02, 2020
Drug Discovery & Development
MAY 02, 2020
Glioblastoma Treatment Using Schizophrenic Drug Plus Radiation
A therapeutic used for the treatment of schizophrenia could be a gateway for targeting glioblastoma, one of the deadlies ...
MAY 18, 2020
Cancer
MAY 18, 2020
How do Ohnologs affect Cancer?
Genetics can be complicated to say the least. Sometimes it can be as simple as a single mutation in one gene that causes ...
MAY 18, 2020
Cancer
MAY 18, 2020
The threat of climate change extends to cancer progression
A study appearing in the American Cancer Society’s CA: A Cancer Journal for Clinicians argues that climate change ...
MAY 26, 2020
Genetics & Genomics
MAY 26, 2020
Some People May be Predisposed to Metastasis if They Get Cancer
Cancer can occur for many reasons and is influenced by many different factors, including genes and the environment. But ...
MAY 28, 2020
Cancer
MAY 28, 2020
Oncologists need more training on how to deliver bad news
A commentary published earlier this spring in the Journal of Clinical Oncology urges for improved training for medical p ...
Loading Comments...